Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The wound care biologics market has experienced noticeable patterns that emerge from the increased importance of advanced wound healing and tissue regeneration therapies. This is exemplified by bioactive products for wound care, including growth factors, cytokines, and stem cell-based treatments. These biologics are designed to enhance the natural process of healing by inducing the multiplication of cells, organ restoration, and formation of new blood vessels. Furthermore, there is a growing interest in tissue-engineered products for use in wound care management. Developed to imitate characteristics and operations exhibited by human tissues, modern wound matrices made from bioengineered materials include skin substitutes as well as grafts.
Besides others, what's making this market go up? Stem cell therapy is one area that has seen significant developments, with better results towards wound healing being realized across different parts of our bodies, such as fatty tissue and bone marrow. Moreover, an increasing trend towards personalized medicine in the field of wound care was also notable. To achieve individual treatment goals, there are studies underway on how patient-specific growth factor formulations can be used as tailored biological therapy. The heterogeneity with respect to both wounds and patients underlines the need for a personalized wound care approach so that it can deliver efficient outcomes alongside patient satisfaction.
Another noticeable trend is toward more frequent use of antimicrobial/anti-biofilm agents in WCB (Wound Care Biologics). The formation of biofilm over chronic wounds makes the healing process much more challenging, thus necessitating antimicrobial activity in such biologics. For example, recent innovations have seen the incorporation of anti-biofilm agents into biological therapies, such as silver technologies and antimicrobial peptides, which significantly improve their efficacy against infections while at the same time promoting faster healing rates. There is additionally a growing shift within the WCB procurement space towards cost-effective solutions. In order to boost accessibility, especially by patients located at various levels of health care provision, manufacturers are now considering scalable and low-cost production techniques for biologic therapeutics.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | New product launches and R&D Amongst major key Players |
Wound Care Biologics Market Highlights:
Global Wound Care Biologics Market Overview
Wound Care Biologics Market Size was valued at USD 1.90 Billion in 2023. The Global Wound Care Biologics industry is projected to grow from USD 2.10 Billion in 2024 to USD 2.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.76% during the forecast period (2024 - 2032).
Wound care biologics products help the body repair wounds naturally by creating an active healing environment. Diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers are the most common wounds treated with biologics.
The wound care biologics market is predicted to develop due to reasons such as the rising prevalence of chronic illnesses and burn injuries, as well as rising healthcare spending. According to the Centers for Disease Control and Prevention (CDC), around 2.8 million persons were admitted to hospitals owing to injuries in 2015. Over the projection period, however, the wound care biologics market will be hampered by high treatment costs, a lack of awareness, and insufficient education and training.
Wound Care Biologics Market Segment Insights
The wound care biologics market has been segmented into product type, wound type, and end user.
Wound Care Biologics Product Type Insights
Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market.
Wound Care Biologics Wound Type Insights
The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.
Wound Care Biologics End User Insights
The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.
Wound Care Biologics Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Some of the key players in the wound care biologics market are
- Integra LifeSciences Corporation (US)
- Smith & Nephew (UK)
- Wright Medical (US)
- Mölnlycke Health Care AB (Sweden)
- MiMedx Group (US)
- Vericel Corporation (US)
- Anika Therapeutics (US)
- Osiris Therapeutics (US)
- Marine Polymer Technologies, Inc. (US)
- Kerecis (Iceland)
- Solsys Medical (US)
- ACell (US)
- Organogenesis (US)
Regional Market Summary
Geographically, the Americas is anticipated to dominate the wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.
Europe is expected to hold the second largest position in the wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.
The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Recent Development
Wright Medical Group Inc. manufactures human replacement components. The company creates replacement joints for the foot, ankle, hand, elbow, shoulder, and other damaged joints. The IN BONE, CLAW, and ORTHOLOC systems for foot and ankles, as well as the MICRONAIL implants for wrist fractures, are among the product lines. Wright's goods are distributed in over 60 countries, with the United States being the main market. Wright Medical Group N.V. was formed in 2015 when the company merged with Tornier of the Netherlands.
MiMedx Group Inc. is a medical equipment manufacturer. Biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, are the company's main emphasis, as well as various biomaterial-based solutions for other medical purposes. The MiMedx Group is a global provider of medical services.
Intended Audience
- Wound Care Biologics Manufacturers and Vendors
- Various Research and Consulting Firms
- Wound Care Biologics Distributors
- Hospitals
Wound Care Biologics Market Segmentation
Wound Care Biologics Market Product Type Outlook
- Skin Substitute
- Human Donor Tissue
- Acellular animal-derived
- Biosynthetic
- Topical Agents
Wound Care Biologics Market Wound Type Outlook
- Ulcers
- Diabetic foot ulcers
- Venous ulcers
- Pressure ulcers
- Other ulcers
- Surgical and Traumatic Wounds
- Burns
Wound Care Biologics Market End User Outlook
- Hospitals
- Clinics
- Other End Users
Wound Care Biologics Market Region Outlook
- Americas
-
- North America
- US
- Canada
- South America
- Europe
-
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
-
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
-
- Middle East
- Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
